AbbVie’s Natrelle awarded supplier agreement from Vizient
This agreement grants Vizient clients enhanced access to Natrelle, the broadest selection of breast implant options on the market
This agreement grants Vizient clients enhanced access to Natrelle, the broadest selection of breast implant options on the market
Liraglutide Injection, 18 mg/3 mL (6 mg/mL) Single-Patient-Use Prefilled Pen is bioequivalent to Victoza Injection, 18 mg/3 mL (6 mg/mL) of Novo Nordisk
A Post Graduate in Science faculty and has a wide experience spanning over 35 years in the field of manufacturing Bulk Drugs and Active Pharmaceutical Intermediaries
India currently hosts more than 10,075 biotech startups
Hyperion results presented at ERS 2025 and simultaneously published in the New England Journal of Medicine
Miels will formally assume the role on January 1, 2026
Brenntag will showcase forward-looking formulations designed to respond to Indonesia’s evolving beauty and self-care needs
Health leaders rally for a national awakening on prevention, mental wellness, and lifestyle reform at ‘Illness to Wellness’ heart care conference
Subscribe To Our Newsletter & Stay Updated